Quest Diagnostics Overview

  • Founded
  • 1967

Founded
  • Status
  • Public

  • Employees
  • 49,000

Employees
  • Stock Symbol
  • DGX

Stock Symbol
  • Investments
  • 65

  • Share Price
  • $148.64

  • (As of Wednesday Closing)

Quest Diagnostics General Information

Description

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Contact Information

Formerly Known As
Corning Clinical Laboratories, Metropolitan Pathology Laboratory
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Stock Exchange
NYS
Primary Office
  • 500 Plaza Drive
  • Secaucus, NJ 07094
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quest Diagnostics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$148.64 $148.48 $120.40 - $158.34 $16.9B 114M 1.08M $10.36

Quest Diagnostics Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 18,269,426 25,005,962 19,730,062 18,620,302
Revenue 10,294,000 10,788,000 9,437,000 7,726,000
EBITDA 2,198,000 3,158,000 2,408,000 1,580,000
Net Income 1,235,000 1,995,000 1,431,000 858,000
Total Assets 13,223,000 13,611,000 14,026,000 12,843,000
Total Debt 4,640,000 4,773,000 4,808,000 5,416,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quest Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quest Diagnostics‘s full profile, request access.

Request a free trial

Quest Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The com
Laboratory Services (Healthcare)
Secaucus, NJ
49,000 As of 2021
000000 - 000

000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000 00000000
Burlington, NC
00000 As of 0000
00000000000

000000

cing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000 00000000
Nottingham, United Kingdom
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quest Diagnostics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Laboratory Corporation of America Corporation Burlington, NC 00000 00000000000
000000 0000000000 Formerly PE-Backed Nottingham, United Kingdom 0 000.00 00000000000 000.00
00000000000 000000 Formerly PE-Backed Houston, TX 000000000 -
000000 00000000 00 Corporation CA 00
000000 00000 00000 Corporate Backed or Acquired Tempe, AZ 0000 0000000000 0
You’re viewing 5 of 9 competitors. Get the full list »

Quest Diagnostics Patents

Quest Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220299524-A1 Identification and quantitation of insulin-like growth factor-i variants by mass spectrometry Pending 19-Mar-2021 00000000000
EP-4104108-A1 Extraction of relevant signals from sparse data sets Pending 13-Feb-2020 000000000
CA-3167609-A1 Extraction of relevant signals from sparse data sets Pending 13-Feb-2020 000000000
CA-3167616-A1 System for determining an underlying cause of anemia Pending 11-Feb-2020 0000000000
EP-4103595-A1 System for determining an underlying cause of anemia Pending 11-Feb-2020 C07K14/805
To view Quest Diagnostics’s complete patent history, request access »

Quest Diagnostics Executive Team (65)

Name Title Board Seat Contact Info
James Davis Chief Executive Officer, Board Member, Executive Committee Member and President
Sam Samad Chief Financial Officer & Executive Vice President
Ruth Clements Vice President and General Manager, Infectious Diseases and Immunology
Richard Adams Vice President & General Manager, Consumer-Initiated Testing
Kristie Dolan General Manager Oncology Franchise
You’re viewing 5 of 65 executive team members. Get the full list »

Quest Diagnostics Board Members (19)

Name Representing Role Since
000000 00000000 Self Board Member, Committee Member of Compensation and Cybersecurity 000 0000
0000 00000000 00.0 Self Board Member, Chairman of Quality and Compliance and Committee Member of Audit & Finance and Governance 000 0000
0000 00000000 Quest Diagnostics Board member 000 0000
00000 00000 Quest Diagnostics Chief Executive Officer, Board Member, Executive Committee Member and President 000 0000
0000000 0000000000 Quest Diagnostics Chairman and Executive Committee Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Quest Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quest Diagnostics Investments & Acquisitions (65)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 08-Dec-2022 0000000000 Hospitals/Inpatient Services 00000 000
00000 000000 28-Nov-2022 000000000 Laboratory Services (Healthcare)
0000 000000 01-Feb-2022 0000000000 00000 Other Healthcare Services 0000000 0
0000000 00000 13-Dec-2021 0000000000 0000 Laboratory Services (Healthcare) 0000000 0
Nationwide Laboratory Services 24-Aug-2021 Merger/Acquisition Laboratory Services (Healthcare) 0000 0000
You’re viewing 5 of 65 investments and acquisitions. Get the full list »

Quest Diagnostics Subsidiaries (16)

Company Name Industry Location Founded
Pack Health Other Healthcare Services Birmingham, AL 2013
000000000 00000000 Other Healthcare Services Espoo, Finland 0000
0000000 0000000000 Laboratory Services (Healthcare) Anderson, SC 0000
000 000000 Laboratory Services (Healthcare) Lewisville, TX 0000
000000000 00000000 Drug Discovery Cleveland, OH 0000
You’re viewing 5 of 16 subsidiaries. Get the full list »

Quest Diagnostics ESG

Risk Overview

Risk Rating

Updated December, 23, 2022

20.98 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,638

Rank

00.00

Percentile

Healthcare

Industry

00 of 636

Rank

00.00

Percentile

Medical Services

Subindustry

00 of 115

Rank

00.00

Percentile

To view Quest Diagnostics’s complete esg history, request access »

Quest Diagnostics Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 07-Jun-2019 000000000 Completed
  • 2 buyers
00000000 000000 22-May-2017 00000 00000 00 0000 Completed
  • 9 buyers
00 000000000 31-Mar-2015 00000 0000000 Completed
  • 2 buyers
000000 000000 21-Apr-2014 000000000000000000 Completed
  • 00000 00000000000
OralDNA Labs 01-May-2009 Merger/Acquisition Completed
You’re viewing 5 of 11 exits. Get the full list »